RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+18.13%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$4.9B
AUM Growth
+$4.9B
(+13%)
Cap. Flow
+$300M
Cap. Flow
% of AUM
6.12%
Top 10 Holdings %
Top 10 Hldgs %
55.22%
Holding
87
New
1
Increased
20
Reduced
10
Closed
10
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$84.7M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$79.8M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$74.4M |
| 4 |
Immunocore
IMCR
|
$63.2M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
$36.9M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$60M |
| 2 |
TSVT
2seventy bio
TSVT
|
$17.9M |
| 3 |
Tandem Diabetes Care
TNDM
|
$15.4M |
| 4 |
Guardant Health
GH
|
$8.02M |
| 5 |
RCOR
Renovacor, Inc.
RCOR
|
$7.56M |
Sector Composition
| 1 | Healthcare | 99.63% |
| 2 | Financials | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alnylam Pharmaceuticals
ALNY
$58.5B
| $400M | 8.17% | 1,683,362 | – | – |
|
|
RXDX
2
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $369M | 7.53% | 3,354,303 +164,698 | +5% | +$18.1M |
|
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $346M | 7.07% | 17,687,772 +1,884,970 | +12% | +$36.9M |
|
|
4
Immunocore
IMCR
$1.62B
| $317M | 6.48% | 5,559,322 +1,107,839 | +25% | +$63.2M |
|
5
Thermo Fisher Scientific
TMO
$186B
| $240M | 4.9% | 435,500 | – | – |
|
|
6
Axsome Therapeutics
AXSM
$6.05B
| $230M | 4.69% | 2,980,482 +1,098,318 | +58% | +$84.7M |
|
7
Masimo
MASI
$7.59B
| $222M | 4.53% | 1,501,493 +61,500 | +4% | +$9.1M |
|
8
PTC Therapeutics
PTCT
$3.92B
| $214M | 4.38% | 5,615,387 -5,193 | -0.1% | -$198K |
|
|
9
Ultragenyx Pharmaceutical
RARE
$2.89B
| $184M | 3.75% | 3,966,915 +1,606,919 | +68% | +$74.4M |
|
10
argenx
ARGX
$43.6B
| $183M | 3.73% | 482,195 +15,000 | +3% | +$5.68M |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $165M | 3.37% | 3,643,114 +1,760,451 | +94% | +$79.8M |
|
12
Establishment Labs
ESTA
$1.2B
| $156M | 3.18% | 2,374,138 +5,000 | +0.2% | +$328K |
|
13
Penumbra
PEN
$10.6B
| $155M | 3.17% | 698,371 | – | – |
|
14
Celldex Therapeutics
CLDX
$1.47B
| $137M | 2.81% | 3,084,215 | – | – |
|
15
Avidity Biosciences
RNA
$5.99B
| $124M | 2.54% | 5,605,566 +434,782 | +8% | +$9.65M |
|
16
Cytokinetics
CYTK
$4.23B
| $118M | 2.41% | 2,574,198 | – | – |
|
17
Illumina
ILMN
$15.8B
| $114M | 2.33% | 564,375 | – | – |
|
18
Natera
NTRA
$23.1B
| $105M | 2.14% | 2,609,283 +400,000 | +18% | +$16.1M |
|
19
Vericel Corp
VCEL
$1.83B
| $81.7M | 1.67% | 3,099,904 | – | – |
|
|
CUTR
20
DELISTED
Cutera, Inc.
CUTR
| $79.5M | 1.62% | 1,798,675 +28,275 | +2% | +$1.25M |
|
21
Acadia Pharmaceuticals
ACAD
$4.38B
| $58.4M | 1.19% | 3,670,938 | – | – |
|
22
Globus Medical
GMED
$8.27B
| $55.5M | 1.13% | 747,685 | – | – |
|
|
AXNX
23
DELISTED
Axonics, Inc. Common Stock
AXNX
| $55.3M | 1.13% | 884,974 | – | – |
|
24
Ventyx Biosciences
VTYX
$171M
| $50.9M | 1.04% | 1,551,778 | – | – |
|
25
Regenxbio
RGNX
$451M
| $41.9M | 0.85% | 1,845,366 | – | – |
|